(Q46477683)

22 December 2017

title

Inhaled iloprost reverses vascular remodeling in chronic experimental pulmonary hypertension (English)

1 reference

22 December 2017

microvasculature remodeling

main subject

1 reference

1

1 reference

22 December 2017

Ardeschir Ghofrani

3

1 reference

22 December 2017

Friedrich Grimminger

10

1 reference

22 December 2017

Werner Seeger

11

1 reference

22 December 2017

Soni Savai Pullamsetti

Soni Pullamsetti

5

0 references

Norbert Weissmann

Norbert Weissmann

9

0 references

Rio Dumitrascu

8

Rio Dumitrascu

1 reference

22 December 2017

Tobias Gessler

7

Tobias Gessler

1 reference

22 December 2017

Andreas Schulz

6

Andreas Schulz

1 reference

22 December 2017

author name string

Hüseyin Yilmaz

2

1 reference

22 December 2017

Kathrin Woyda

4

1 reference

22 December 2017

language of work or name

English

0 references

publication date

5 May 2005

1 reference

22 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

22 December 2017

volume

172

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

358-363

1 reference

22 December 2017

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

Inhaled iloprost for severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

Activation and pulmonary toxicity of pyrrolizidine alkaloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

Ultrasonic nebulization for efficient delivery of surfactant in a model of acute lung injury. Impact on gas exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

New treatments for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

EndothelinA receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

Suppressive effect of pulmonary hypertension and leukocyte activation by inhaled prostaglandin E1 in rats with monocrotaline-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

Monocyte membrane type 1-matrix metalloproteinase. Prostaglandin-dependent regulation and role in metalloproteinase-2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

NF-Y and Sp1 cooperate for the transcriptional activation and cAMP response of human tissue inhibitor of metalloproteinases-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200502-296OC

10.1164/RCCM.200502-296OC

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

15879421

1 reference

22 December 2017